The Center of Excellence for MR research, under the direction of Dr. Siegfried Trattnig, has the current, most technologically advanced MR scanners, with very high field strengths of 3 Tesla and 7 Tesla. Established with a $4 million grant, the center was designed to provide the latest in MR technology and to develop sequences and methods for the 7 Tesla scanner. As Professor Trattnig pointed out, “The 7T is an experimental scanner and contrary to routine scanner at lower field strengths, comes without implemented sequence protocols and coils. We have to optimize sequences for 7T and develop new ones for projects. We have to collaborate with companies to get 7T coils specific for our research projects. With all this effort we must prove it’s at least as good as the 3T scanner.” But, the promise of the 7T is enormous. This scanner can be used to study osteoarthritis, diabetes and is capable of improved functional MRI, which will enhance studies of neuronal networks in the brain in psychology and neurological diseases and multinuclear spectroscopy, which can provide metabolic insight into a large number of diseases from cancer to muscular diseases. In addition, therapeutic monitoring is much improved at the 7 Tesla field strength with its functional and metabolic capabilities. Worldwide, only a small number of 7 Tesla MR machines are in use. This new 3/7 Tesla Research Center at the Medical University of Vienna and the General Hospital of Vienna will continue to help provide the most up-to-date patient care, as well as advance the research in functional and metabolic imaging and about new uses for contrast agent application. This, in turn, will result in new opportunities for training and education. Certainly, this major investment by the MUV and the General Hospital in Vienna will further establish Vienna as a site of international research. This investment was undertaken in cooperation with Fa. Siemens. The results obtained from these high-field MR machines will allow a better understanding of brain tumors, psychiatric diseases, cancer in general and metabolic diseases, such as diabetes mellitus. Another special focus is on the biochemical and molecular imaging of cartilage in order to arrive at an earlier diagnosis of osteoarthritis, as well as to enable an adequate follow-up after medication or operative therapy/intervention.